首頁 > 市場調查報告書 > 醫療設備

感測器生技設備

市場調查報告書

商品編碼

1527813

全球生物感測器市場：市場規模、佔有率、成長分析 - 按類型、按產品、按技術、按組件、按應用、按最終用戶、按地區、行業預測，2024-2031 年

Biosensors Market Size, Share, Growth Analysis, By Type, Product, Technology, Component, Application, End-User, and Region - Industry Forecast 2024-2031

出版日期: 2024年07月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球生物感測器市場規模將達到約267.6億美元，2023年將達到289億美元，2024-2031年預測期間複合年成長率為8.0%，2031年將達到535億美元，預計將達到90美元百萬。

由於奈米技術和生物技術的進步，生物感測器市場正在經歷快速成長。這些下一代感測器提高了檢測細菌細胞和其他生物分子的效率和準確性，並在醫療保健、農業和食品安全等多個領域中得到應用。醫療保健產業依靠生物感測器進行血糖監測、尿道結石檢測、藥物濃度追蹤等。食品和飲料行業也使用生物感測器進行品管和安全。將生物感測器整合到智慧型手錶等穿戴式設備中正在進一步擴大市場潛力。隨著技術的進步，生物感測器將在各行業中發揮越來越重要的作用。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 義大利
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Abbott Laboratories（US）
Roche Diagnostics-（Switzerland）
Johnson & Johnson（US）
Medtronic（Ireland）
Siemens Healthcare GmbH（Germany）
GE Healthcare（US）
LifeScan, Inc.（US）
Bio-Rad Laboratories（US）
Nova Biomedical（US）
Dexcom（US）
AgaMatrix, Inc.（US）
Biosensors International Group, Ltd.（Singapore）
Sysmex Corporation（Japan）
F. Hoffmann-La Roche AG（Switzerland）
PTS Diagnostics（US）
Acon Laboratories, Inc.（US）
Medtronic Diabetes（US）
Universal Biosensors, Inc.（Australia）
Analog Devices, Inc.（US）
Lifescan Medical Devices Co., Ltd.（China）
Biosensing Instrument, Inc.（US）
Miraculins Inc.（Canada）
I-SENS, Inc.（South Korea）
LifeSensors, Inc.（US）
GlySens Incorporated（US）

簡介目錄

Product Code: SQMIG45J2077

Global Biosensors Market size was valued at around USD 26.76 billion in 2022 and is poised to grow from USD 28.9 billion in 2023 to USD 53.59 billion by 2031, at a CAGR of 8.0% over the forecast period (2024-2031).

The biosensor market is experiencing rapid growth driven by advancements in nanotechnology and biotechnology. These next-generation sensors offer enhanced efficiency and accuracy in detecting bacterial cells and other biomolecules, finding applications in diverse sectors like healthcare, agriculture, and food safety. The healthcare industry is a major adopter, utilizing biosensors for glucose monitoring, UTI detection, and drug level tracking. Additionally, the food and beverage industry employs biosensors for quality control and safety. The integration of biosensors into wearable devices, such as smartwatches, is further expanding market potential. As technology continues to evolve, biosensors are poised to play an increasingly critical role in various industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biosensors Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biosensors Market Segmental Analysis

Global Biosensors Market is segmented by type, product, technology, component, application and region. Based on type, the market is segmented into sensor patch, and embedded device. Based on product the market is segmented into wearable biosensors (wristwear, eyewear, footwear, neckwear, bodywear and others) and non-wearable biosensors. Based on technology, the market is segmented into electrochemical biosensors (amperometric, potentiometric and conductometric), optical biosensors (SPR, colorimetric and fluorescence), piezoelectric biosensors (acoustic and microcantilever), thermal biosensors, and nanomechanical biosensors. Based on component, the market is segmented into bioreceptor molecules, biological elements, and transducer. Based on application, the market is segmented into POC (glucose monitoring, cardiac marker, infectious disease detection, coagulation monitoring, pregnancy testing, blood gas & electrolyte detection, detection of tumor or cancer marker, urinalysis testing and cholesterol testing), home diagnosis (glucose monitoring, pregnancy testing and cholesterol testing), research labs, environmental monitoring, food and beverages and biodefense. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Biosensors Market

Nanotechnology has revolutionized biosensors, creating devices with nanoscale materials that enhance biological signal detection and transduction. These sensors, often integrated with electrical systems, utilize nanomaterials like nanotubes, nanowires, and nanoparticles to detect various biomolecules. Applications span from glucose monitoring to fluorescence-based detection and biomolecular analysis, demonstrating the versatility of nanotechnology in biosensing.

Restraints in the Global Biosensors Market

The biosensor market faces significant challenges hindering widespread adoption. High production costs and limited demand outside healthcare have slowed the commercialization of this promising technology. Expanding biosensor applications into areas like biodefense, military, and environmental monitoring is hampered by insufficient research and development. Additionally, consumer acceptance, price sensitivity, and concerns about product reliability further impede market growth.

Market Trends of the Global Biosensors Market

Wearable biosensors are driving significant growth in the biosensor market. These small, non-invasive devices, often integrated into smartwatches and fitness trackers, monitor various health parameters like heart rate, blood glucose, and sleep patterns. Advancements in sensor technology have made them smaller, more efficient, and suitable for continuous wear. The increasing prevalence of chronic diseases, coupled with the rise of digital health and remote patient monitoring, is fueling demand. As wearable biosensors become more accessible and affordable, they are poised to revolutionize healthcare by providing individuals with valuable insights into their health and enabling proactive management of chronic conditions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Patent Analysis
Value Chain Analysis
Trade Analysis
Ecosystem of the Market
Case Study Analysis
Regulatory Landscape
PESTEL Analysis
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Biosensors Market by Type

Market Overview
Sensor Patch
Embedded Devices

Biosensors Market by Product

Market Overview
Wearable Biosensors
- Wristwear
- Eyewear
- Footwear
- Neckwear
- Bodywear
- Others
Wearable Biosensors

Biosensors Market by Technology

Market Overview
Electrochemical Biosensors
- Amperometric
- Potentiometric
- Conductometric
Optical Biosensors
- SPR
- Colorimetric
- Fluorescence
Piezoelectric Biosensors
- Acoustic
- Microcantilever
Thermal Biosensors
Nanomechanical Biosensors

Biosensors Market by Component

Market Overview
Bioreceptor Molecules
Biological Elements
Transducer

Biosensors Market by Application

Market Overview
POC
- Glucose Monitoring
- Cardiac Marker
- Infectious Disease Detection
- Coagulation Monitoring
- Pregnancy Testing
- Blood Gas & Electrolyte Detection
- Detection of Tumor or Cancer Marker
- Urinalysis Testing
- Cholesterol Testing
Home Diagnosis
- Glucose Monitoring
- Pregnancy Testing
- Cholesterol Testing
Research Labs
Environmental Monitoring
Food and Beverages
Biodefense

Biosensors Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- Italy
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics -(Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthcare GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeScan, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International Group, Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PTS Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acon Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Diabetes (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Universal Biosensors, Inc. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Analog Devices, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifescan Medical Devices Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensing Instrument, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miraculins Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
I-SENS, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeSensors, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlySens Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments